AVTX
Price
$13.25
Change
-$0.00 (-0.00%)
Updated
Nov 11 closing price
CELC
Price
$15.70
Change
-$0.00 (-0.00%)
Updated
Nov 11 closing price
2 days until earnings call
Ad is loading...

AVTX vs CELC

Header iconAVTX vs CELC Comparison
Open Charts AVTX vs CELCBanner chart's image
Avalo Therapeutics
Price$13.25
Change-$0.00 (-0.00%)
Volume$170.39K
CapitalizationN/A
Celcuity
Price$15.70
Change-$0.00 (-0.00%)
Volume$149.36K
CapitalizationN/A
AVTX vs CELC Comparison Chart
Loading...
AVTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CELC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
AVTX vs. CELC commentary
Nov 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVTX is a Hold and CELC is a Hold.

COMPARISON
Comparison
Nov 13, 2024
Stock price -- (AVTX: $13.20 vs. CELC: $15.70)
Brand notoriety: AVTX and CELC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVTX: 649% vs. CELC: 58%
Market capitalization -- AVTX: $128.04M vs. CELC: $581.37M
AVTX [@Biotechnology] is valued at $128.04M. CELC’s [@Biotechnology] market capitalization is $581.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $476.71B to $0. The average market capitalization across the [@Biotechnology] industry is $2.81B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVTX’s FA Score shows that 1 FA rating(s) are green whileCELC’s FA Score has 0 green FA rating(s).

  • AVTX’s FA Score: 1 green, 4 red.
  • CELC’s FA Score: 0 green, 5 red.
According to our system of comparison, both AVTX and CELC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVTX’s TA Score shows that 4 TA indicator(s) are bullish while CELC’s TA Score has 7 bullish TA indicator(s).

  • AVTX’s TA Score: 4 bullish, 6 bearish.
  • CELC’s TA Score: 7 bullish, 2 bearish.
According to our system of comparison, CELC is a better buy in the short-term than AVTX.

Price Growth

AVTX (@Biotechnology) experienced а -2.51% price change this week, while CELC (@Biotechnology) price change was +2.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.24%. For the same industry, the average monthly price growth was +11.71%, and the average quarterly price growth was +7.66%.

Reported Earning Dates

AVTX is expected to report earnings on Apr 01, 2024.

CELC is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (+1.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CELC($553M) has a higher market cap than AVTX($122M). AVTX YTD gains are higher at: 45.055 vs. CELC (7.756). AVTX has higher annual earnings (EBITDA): -26.72M vs. CELC (-76.03M). CELC has more cash in the bank: 283M vs. AVTX (93.4M). AVTX has less debt than CELC: AVTX (548K) vs CELC (96.5M). AVTX has higher revenues than CELC: AVTX (807K) vs CELC (0).
AVTXCELCAVTX / CELC
Capitalization122M553M22%
EBITDA-26.72M-76.03M35%
Gain YTD45.0557.756581%
P/E RatioN/AN/A-
Revenue807K0-
Total Cash93.4M283M33%
Total Debt548K96.5M1%
FUNDAMENTALS RATINGS
AVTX vs CELC: Fundamental Ratings
AVTX
CELC
OUTLOOK RATING
1..100
7581
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
40
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
4047
P/E GROWTH RATING
1..100
1100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CELC's Valuation (40) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for AVTX (98) in the Pharmaceuticals Other industry. This means that CELC’s stock grew somewhat faster than AVTX’s over the last 12 months.

CELC's Profit vs Risk Rating (100) in the Miscellaneous Commercial Services industry is in the same range as AVTX (100) in the Pharmaceuticals Other industry. This means that CELC’s stock grew similarly to AVTX’s over the last 12 months.

CELC's SMR Rating (96) in the Miscellaneous Commercial Services industry is in the same range as AVTX (100) in the Pharmaceuticals Other industry. This means that CELC’s stock grew similarly to AVTX’s over the last 12 months.

AVTX's Price Growth Rating (40) in the Pharmaceuticals Other industry is in the same range as CELC (47) in the Miscellaneous Commercial Services industry. This means that AVTX’s stock grew similarly to CELC’s over the last 12 months.

AVTX's P/E Growth Rating (1) in the Pharmaceuticals Other industry is significantly better than the same rating for CELC (100) in the Miscellaneous Commercial Services industry. This means that AVTX’s stock grew significantly faster than CELC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVTXCELC
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 19 days ago
82%
Bullish Trend 15 days ago
83%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 12 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
AVTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CELC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RVPHX8.810.09
+1.03%
Royce Smaller-Companies Growth Invmt
BGRWX32.450.07
+0.22%
Barrett Growth Retail
HLEZX20.140.03
+0.15%
Harding Loevner Instl Emerg Mkts Z
YACKX25.72N/A
N/A
AMG Yacktman I
ATEZX163.41-0.14
-0.09%
AB Sustainable Global Thematic Z

AVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVTX has been loosely correlated with FGEN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if AVTX jumps, then FGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVTX
1D Price
Change %
AVTX100%
-0.83%
FGEN - AVTX
57%
Loosely correlated
+5.29%
MEOBF - AVTX
46%
Loosely correlated
+8.79%
CELC - AVTX
39%
Loosely correlated
-0.95%
MRSN - AVTX
37%
Loosely correlated
-1.56%
XLO - AVTX
36%
Loosely correlated
+10.09%
More

CELC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELC has been loosely correlated with SNDX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if CELC jumps, then SNDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELC
1D Price
Change %
CELC100%
-0.95%
SNDX - CELC
41%
Loosely correlated
-0.14%
ALLO - CELC
40%
Loosely correlated
-0.32%
INZY - CELC
40%
Loosely correlated
-0.75%
ZYME - CELC
40%
Loosely correlated
+4.21%
PLRX - CELC
40%
Loosely correlated
-3.13%
More